Efficacy and safety of anti LINGO-1 for the treatment of relapsing forms of multiple sclerosis: Design of the phase 2 SYNERGY trial

Authors
Category Primary study
JournalEuropean Journal of Neurology
Year 2014
This article has no abstract
Epistemonikos ID: 43374eae885d6c529e062644125f61f5e936d4e0
First added on: Feb 06, 2025